PF-06649298 is an Orally Active SLC13A5 (NaCT) Inhibitor, Regulating Glucose and Lipid Metabolism
The SLC13 family comprises five family members. co-transports, NaS1 and NaS2. Sodium-coupled citrate transporter (NaCT) and NaDC1 and NaDC3 are responsible for transporting cellular anionic intermediates. For example, citrate can…